Revvity Long-term Debt / Capital 2010-2025 | RVTY
Current and historical long-term debt / capital for Revvity (RVTY) from 2010 to 2025. Long-term debt / capital can be defined as a measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Revvity long-term debt / capital for the three months ending June 30, 2025 was 0.29.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.202B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.316B | 26.95 |
| CVS Health (CVS) | United States | $75.446B | 9.38 |
| Elevance Health (ELV) | United States | $64.396B | 8.66 |
| Cencora (COR) | United States | $55.472B | 19.30 |
| DiDi Global (DIDIY) | China | $25.980B | 27.60 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.30 |
| Natera (NTRA) | United States | $18.843B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| ICON (ICLR) | Ireland | $15.316B | 14.74 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.929B | 0.00 |
| CochLear (CHEOY) | Australia | $13.403B | 0.00 |
| Solventum (SOLV) | United States | $12.763B | 13.51 |
| Medpace Holdings (MEDP) | United States | $12.728B | 33.68 |
| Viatris (VTRS) | United States | $10.868B | 3.73 |
| Avantor (AVTR) | United States | $9.533B | 13.85 |
| Sonic Healthcare (SKHHY) | Australia | $9.208B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.791B | 17.23 |
| HealthEquity (HQY) | United States | $8.281B | 36.27 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.884B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 30.08 |
| BrightSpring Health Services (BTSG) | United States | $3.600B | 33.03 |
| Sotera Health (SHC) | United States | $3.489B | 19.82 |
| Surgery Partners (SGRY) | United States | $2.876B | 37.40 |
| Organon (OGN) | United States | $2.592B | 2.75 |
| Concentras Parent (CON) | United States | $2.576B | 14.89 |
| GeneDx Holdings (WGS) | United States | $2.423B | 93.31 |
| Alignment Healthcare (ALHC) | United States | $2.346B | 0.00 |
| Progyny (PGNY) | United States | $1.989B | 43.77 |
| PACS (PACS) | United States | $1.792B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.789B | 35.79 |
| Premier (PINC) | United States | $1.739B | 13.20 |
| Ardent Health (ARDT) | United States | $1.525B | 6.50 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.824B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.753B | 7.05 |
| CareDx (CDNA) | United States | $0.712B | 11.12 |
| Embecta (EMBC) | United States | $0.662B | 4.46 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| So-Young (SY) | China | $0.513B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.506B | 0.00 |
| LifeMD (LFMD) | United States | $0.494B | 0.00 |
| Omada Health (OMDA) | $0.478B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.477B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 10.28 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.406B | 0.00 |
| Enhabit (EHAB) | United States | $0.344B | 28.29 |
| Oncology Institute (TOI) | United States | $0.336B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.286B | 0.00 |
| Beauty Health (SKIN) | United States | $0.222B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| Sera Prognostics (SERA) | United States | $0.118B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| KindlyMD (NAKA) | United States | $0.077B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |